Strong Q1 Can't Shake the Guidance Pullback
Share India delivered its strongest quarter on record — 47% PAT growth to ₹124.4 Cr — but reiterated a 20% full-year revenue target that implies Q2-Q4 deceleration from Q1's 31% pace. The market's 9.22% sell-off by day 3 suggests it read that restatement as caution, not confidence.
The tension is clean. Q1 was genuinely strong — ₹448.1 Cr revenue (+31% YoY), ₹124.4 Cr PAT (+47% YoY) driven by MTF interest income (₹470 Cr book generating recurring revenue), new PMS AUM at ₹150 Cr, and merchant banking closing ₹367 Cr in transactions. That's the strongest quarter in Share India's history. Yet the call did something the market clearly didn't expect: management reiterated FY27 guidance of ~20% revenue growth rather than raising it. At Q1's 31% pace, that implies Q2-Q4 will average roughly 17-18% — a material step down. The street's reaction was swift: 9.22% sell-off by day 3 and declining volume. That's not a market punishing the quarter; it's a market re-pricing the trajectory.
Where the profit came from
₹448.1 Cr
+31.2% YoY
₹124.4 Cr
+47.4% YoY, +114.4% QoQ
27.6%
elevated; MTF interest + prop mix
~20%
vs Q1's 31% (deceleration flagged)
The 47% PAT jump is organic, not a one-time bounce. MTF interest income from the ₹470 Cr book is recurring. PMS (₹150 Cr AUM launched in Q1) is generating advisory fees. Merchant banking transactions (SME and mainboard IPOs) are taking commission. Subsidiaries (IFSC, Fincap, Capital Services) all swung to profitability. OPM holding steady at 44.8% despite regulatory headwinds shows operational leverage — new revenue streams are diversifying the mix away from volatile proprietary trading.
But here's where caution enters the room. On a 31% Q1 result, a 20% full-year target reads as management telegraphing near-term headwinds: RBI restrictions on proprietary trading funding, SEBI tightening F&O leverage rules, and the natural deceleration that follows a strong quarter in volatile markets. Management isn't wrong to be cautious — the regulatory cycle is real — but the street interpreted the unchanged guidance as a miss on momentum and executed a 9% liquidation by day 3.
What management's claims actually deliver
Strongest quarterly result to date; ₹124.4 Cr PAT
Q4 PAT was ₹58 Cr; Q1 is 114% higher. Figures corroborate.
Supported
31% YoY revenue, ~48% YoY PAT growth
Delivered 31.2% revenue, 47.4% PAT; variance negligible
Supported
FY27 revenue growth targeting ~20%
At 20% full-year and 31% Q1, Q2-Q4 average ~17-18%; credible but implies caution
Supported (conservative)
MTF targeting ₹1000 Cr by FY29
Prior guidance: ₹650 Cr by FY27. At 20% growth, MTF tracks to ~₹570-610 Cr by FY27 EOY. Target pushed back 2 years.
Supported but timeline extended (miss acknowledged)
What shifted on this call
MTF target timeline extended: Was ₹650 Cr by FY27, now ₹1000 Cr by FY29. Acknowledges prior target was optimistic.
New revenue quantified and operationalized: PMS ₹150 Cr AUM (launching Q1; targeting ₹250 Cr by EOY). Merchant banking ₹367 Cr (first mainboard IPO 12x oversubscribed). Share India Cred ₹74 Cr underwritten (profitable from day one). All now live, not promises.
Branch expansion formalized with accountability: 30 branches in 24 months (7 open). Each branch requires ₹15 Cr MTF book in 8 months for break-even. Hard stop at 12 months if unprofitable. Specific targets and data-driven discipline vs prior aspirational talk.
Regulatory guidance extended: Clarity on RBI funding rules and SEBI F&O leverage caps pushed into FY28. Near-term headwinds flagged but not resolved.
The bull and bear case
The bull narrative: Diversification is real and live. PMS, merchant banking, and wealth advisory are no longer strategic concepts — they're revenue-generating in Q1. All subsidiary businesses are profitable (IFSC recovery is meaningful). The ₹2760 Cr net worth provides capex flexibility for a 30-branch roll-out. Regulatory tightening on proprietary trading is forcing industry consolidation; smaller brokers facing capital pressures will exit. Share India's technology edge (Techyon platform, Silverleaf HFT acquisition, retail algo trading via uTrade), scale, and regional footprint position it to capture market share. The 8-month payback model for branches is credible (7 branches validating it). Proprietary trading, while 50-52% of current profit, is declining as a % of total (was 85-90% revenue eight years ago). Secular tailwinds: Indian capital market penetration accelerating, fintech adoption, retail investor base growing.
The bear case: Q1 delivered 31% revenue growth, but full-year guidance of 20% implies a 36% deceleration. That's not normal seasonality; it's management expecting near-term headwinds to bite. Proprietary trading is still 50-52% of profit — regulatory shifts on capital requirements or leverage caps could materially compress this. The MTF target was extended by 2 years, signalling prior guidance was too optimistic. New products (PMS, AIF, merchant banking) are early-stage; execution risk on ramp is high. The market's post-result reaction was negative: down 9.22% by day 3, volume declining, institutional buying minimal (FII up only 0.1pp to 1.54%). The street didn't believe the narrative and repriced accordingly.
How the street is positioned
The stock closed at ₹191.57 before the result (Fri Jul 24, 2026) and fell to ₹178.48 by Jul 31. Post-result action: day 1 down 1.66%, day 3 down 9.22% (material sell-off), day 5 down 6.83%. Volume declining. This is the market's verdict: good numbers, but disappointed guidance. The stock is now 15.4% below its all-time high of ₹211 but +54.65% from the 52-week low of ₹115.41 — in neutral territory with no conviction in either direction.
Ownership: FII ticked up from 1.44% to 1.54% (+0.1pp), but from a very low level — this is not institutional accumulation, it's indifference. DII also marginally up (+0.06pp to 0.48%). Promoter holding flat at 48.62%. The lack of institutional enthusiasm post-result, despite strong numbers, signals the street is waiting for regulatory clarity and proof that diversification can offset near-term prop trading deceleration. The 9% sell-off and declining volume are red flags on conviction.
Risks, ranked by holder concern
Regulatory tightening (RBI funding curbs, SEBI F&O rules)
HighProprietary trading is 50-52% of profit. RBI restrictions on proprietary desk funding and SEBI leverage caps could materially reduce prop profitability near-term. Management flagged this as central to the 20% guidance. If regulatory impact is sharper than expected, the full-year target misses.
Proprietary trading exposure remains concentrated
MediumDespite 8-year push to diversify (85-90% prop revenue → 60%), prop is still 50-52% of profit. Geopolitical volatility, market swings, and regulatory policy are all vectors. Diversification must accelerate faster to de-risk this dependency.
Branch expansion execution at scale (30 in 24 months)
Medium7 branches open; each needs ₹15 Cr MTF in 8 months for break-even. Model unproven at scale. Regional demand variability (Hyderabad, Indore, Banaras differ in product affinity) adds complexity. Payback delay from 8 to 10-12 months would materially extend capex ROI.
New product ramp risk (PMS, AIF, merchant banking)
MediumPMS ₹150 Cr AUM (Q1 launch) targeting ₹250 Cr by EOY — aggressive timeline. AIF launching Q3 (regulatory approval pending). Merchant banking 12x IPO oversubscribed but still early-stage. Revenue scale and margins unproven. Competition from Motilal Oswal, Anand Rathi is intense.
Earnings quality: MTF and prop trading sensitivity
LowQ1 benefited from MTF interest income on a ₹470 Cr growing book. If market volatility spikes and MTF clients hit margin calls, book could shrink, denting interest income. Similarly, prop trading returns are sensitive to market swings. Not a fundamental issue, but volatility vector.
What to watch next
1 · Q2 revenue run-rate
Does the 20% full-year guidance hold? If Q2 comes in at 18-22% YoY, management caution looks justified and FY27 is on track. Below 15% signals sharper deceleration driven by regulatory or market stress. This single metric determines whether the thesis holds.
2 · AIF launch (Q3) and PMS AUM trajectory
AIF regulatory approval in process; Q3 launch expected. PMS needs to hit ₹250 Cr AUM by FY27 EOY (currently ₹150 Cr in month 3 of Q1). If both scale on plan, diversification momentum is real. If either misses, it casts doubt on management's ramp forecasts.
3 · Regulatory clarity on proprietary trading
RBI and SEBI are still writing the rulebook. Clarity on capital requirements, leverage caps, and F&O position limits is critical. If regulations stabilize with manageable compliance costs, prop headwinds ease and 20% guidance looks conservative. If tighter, prop dependency becomes a structural ceiling.
4 · Branch payback validation as roll-out accelerates
7 branches achieved 8-month payback. Will it hold at 15, 20, 30 branches? Market acquisition costs, regional hiring, and operational scaling are all variables. Any indication that payback is extending beyond 8 months flags execution risk on the 30-branch plan.
The single number to track
Organic FY27 revenue growth excluding new ventures. Strip out the 2-3pp contribution from nascent products (PMS, AIF, merchant banking), and what does core broking deliver? That's where regulatory headwinds and market normalization will show up first. If core broking (MTF + retail + proprietary) is decelerating faster than new products ramp, the 20% guidance is at risk. If core holds ~15-18% and new products add 2-3pp to reach 20%, the narrative holds and downside is limited. Management doesn't break this out explicitly, so read it from segment notes and investor calls in coming quarters.
Share India executed well in Q1 — diversification is operationalized, subsidiaries are profitable, new revenue streams are live. But the 20% full-year guidance telegraphs near-term caution on regulatory and market headwinds. The street's 9% sell-off by day 3 and declining volume signal it expected more bullish forward guidance and doesn't yet believe diversification will fully offset prop trading deceleration.
This is steady execution, not a step-change. Valuation risk has likely repriced lower post-result, creating long-term optionality if regulatory clarity improves and diversification accelerates. But near-term, the stock is data-dependent on Q2 run-rate, AIF/PMS scaling, and any sign that core broking is decelerating faster than expected. Track the organic revenue number; it's where the truth lives.
Informational and educational content only. Not investment advice.